Cargando…
Sorafenib-related generalized eruptive keratoacanthomas (Grzybowski syndrome): a case report
BACKGROUND: Sorafenib is an oral multikinase inhibitor that targets Raf serine/threonine receptor tyrosine kinases and inhibits tumor cell growth and angiogenesis. Cutaneous toxicities of sorafenib are common, including cutaneous eruptions (such as truncal erythema and seborrheic-dermatitis-like cha...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454110/ https://www.ncbi.nlm.nih.gov/pubmed/34544494 http://dx.doi.org/10.1186/s13256-021-03037-4 |